Metreleptin
Myalept, Myalepta (metreleptin) is a protein pharmaceutical. Metreleptin was first approved as Myalept on 2014-02-24. It is used to treat lipodystrophy in the USA. It has been approved in Europe to treat familial partial lipodystrophy.
| Trade Name | Myalepta |
|---|---|
| Common Name | Metreleptin |
| Indication | familial partial lipodystrophy, lipodystrophy |
| Drug Class | Leptin derivatives |
